Amgen, Inc.
NASDAQ: AMGN
$253.50
+$1.47 (+0.6%)
Closing price January 22, 2021
The 2021 Dogs of the Dow are now known, and investors who may want to follow this investing strategy have got some thinking to do.
21 days ago
Tuesday's top analyst upgrades and downgrades included Amgen, Amphenol, Continental Resources, EOG Resources, FedEx, IMAX and Splunk.
24 days ago
Last Updated: 24 days ago
One popular investment strategy, known as the Dogs of the Dow, has performed better than last year. What's ahead for the dogs in 2021?
1 month ago
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
1 month ago
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
1 month ago
Thursday's top analyst upgrades and downgrades included Amgen, Boeing, eBay, Etsy, Fastly, Fiverr, Ford, General Electric, Gilead Sciences, Pinterest and Six Flags.
2 months ago
Last Updated: 2 months ago
Amgen and Gilead released their most recent financial results after the closing bell on Wednesday.
2 months ago
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
2 months ago
Tuesday's top analyst upgrades and downgrades included Advanced Micro Devices, Amazon.com, Amgen, Biogen, Hasbro, Kinder Morgan, SAP, Spotify and Twitter.
2 months ago
Last Updated: 2 months ago
Monday's top analyst upgrades and downgrades included Advanced Micro Devices, Amgen, Asana, Baidu, First Solar, Mattel, Mirati Therapeutics, Palantir Technologies, Pinterest, SAP and Zscaler.
2 months ago
Last Updated: 2 months ago
Roughly a third of the Dow Jones industrial average components are scheduled to report their latest quarterly reports this week.
2 months ago
Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After all, many investors missed the bulk of the recovery from March’s panic...
3 months ago
The September 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
3 months ago
24/7 Wall St. has been reviewing many sectors for leadership heading into earnings. One area that can offer some defensive strategies is biotech and pharmaceuticals.
3 months ago
Friday's top analyst upgrades and downgrades included AMD, Amazon.com, Amgen, Chevron, Exxon Mobile, General Electric, IBM, Lowe's Companies, Marvell Technology, Rocket Companies, 3D Systems and ...
3 months ago
Last Updated: 3 months ago